Literature DB >> 31807919

Cerium-doped flower-shaped ZnO nano-crystallites as a sensing component for simultaneous electrochemical determination of epirubicin and methotrexate.

Nezhat Jandaghi1, Shohreh Jahani2, Mohammad Mehdi Foroughi3, Maryam Kazemipour1, Mehdi Ansari4.   

Abstract

A glassy carbon electrode (GCE) was modified with cerium-doped ZnO nanoflowers (Ce-ZnO/GCE) to obtain a sensor for direct simultaneous detection of the cancer drugs epirubicin and methotrexate. XRD, SEM and EDX techniques were used to characterize their morphology and structure. Electrochemical impedance spectroscopy was applied to characterize the electrochemical features of the modified GCE. The experimental conditions were optimized. Diffusion coefficients and heterogeneous rate constants were determined for the oxidation of epirubicin. The differential pulse voltammetric response to epirubicin has a peak near 0.7 V (vs. Ag/AgCl at a scan rate of 50 mV s-1) and is linear in the 0.01 to 600 μM concentration range, and the detection limit is 2.3 nM (S/N = 5). The differential pulse voltammetric response to methotrexate has a peak near 0.75 V (vs. Ag/AgCl and the same scan rate) and is linear in the 0.01 to 500 μM concentration range, and the detection limit is 6.3 nM (S/N = 5). The method was applied to the simultaneous determination of epirubicin and methotrexate in pharmaceutical injections and in spiked diluted blood specimens. Graphical abstractSchematic of an electrochemical sensor based on Ce-doped ZnO nano-flowers modified glassy carbon electrode for detecting epirubicin.

Entities:  

Keywords:  Cerium-doped flower-shaped ZnO nano-crystallites; Epirubicin; Methotrexate; Modified electrode; Voltammetry

Mesh:

Substances:

Year:  2019        PMID: 31807919     DOI: 10.1007/s00604-019-4016-2

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   5.833


  15 in total

1.  The effect of ultrasonic irradiation on the morphology of NiO/Co3O4 nanocomposite and its application to the simultaneous electrochemical determination of droxidopa and carbidopa.

Authors:  Reyhaneh Torkzadeh-Mahani; Mohammad Mehdi Foroughi; Shohreh Jahani; Maryam Kazemipour; Hadi Hassani Nadiki
Journal:  Ultrason Sonochem       Date:  2019-04-02       Impact factor: 7.491

2.  Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothelial Cancer Research Group.

Authors:  M Kuroda; T Kotake; H Akaza; S Hinotsu; T Kakizoe
Journal:  Jpn J Clin Oncol       Date:  1998-08       Impact factor: 3.019

3.  Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy.

Authors:  Hend Abdelrady; Rania M Hathout; Rihab Osman; Imran Saleem; Nahed D Mortada
Journal:  Eur J Pharm Sci       Date:  2019-03-21       Impact factor: 4.384

4.  Determination of methotrexate in spiked human blood serum using multi-frequency electrochemical immittance spectroscopy and multivariate data analysis.

Authors:  Sereilakhena Phal; Britta Lindholm-Sethson; Paul Geladi; Andrey Shchukarev; Solomon Tesfalidet
Journal:  Anal Chim Acta       Date:  2017-08-28       Impact factor: 6.558

5.  Bimetallic gold/silver nanoclusters as a fluorescent probe for detection of methotrexate and doxorubicin in serum.

Authors:  Feifei Meng; Feng Gan; Gang Ye
Journal:  Mikrochim Acta       Date:  2019-05-23       Impact factor: 5.833

6.  Determination of vanillin by using gold nanoparticle-modified screen-printed carbon electrode modified with graphene quantum dots and Nafion.

Authors:  Gema M Durán; Eulogio J Llorent-Martínez; Ana M Contento; Ángel Ríos
Journal:  Mikrochim Acta       Date:  2018-03-03       Impact factor: 5.833

Review 7.  Metal oxide nanoparticles in electrochemical sensing and biosensing: a review.

Authors:  Jaise Mariya George; Arun Antony; Beena Mathew
Journal:  Mikrochim Acta       Date:  2018-07-04       Impact factor: 5.833

8.  Interaction of anticancer drug methotrexate with DNA analyzed by electrochemical and spectroscopic methods.

Authors:  Bushra Rafique; Ahmad M Khalid; Kalsoom Akhtar; Abdul Jabbar
Journal:  Biosens Bioelectron       Date:  2012-12-27       Impact factor: 10.618

9.  Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

Authors:  Christopher J Poole; Helena M Earl; Louise Hiller; Janet A Dunn; Sarah Bathers; Robert J Grieve; David A Spooner; Rajiv K Agrawal; Indrajit N Fernando; A Murray Brunt; Susan M O'Reilly; S Michael Crawford; Daniel W Rea; Peter Simmonds; Janine L Mansi; Andrew Stanley; Peter Harvey; Karen McAdam; Liz Foster; Robert C F Leonard; Christopher J Twelves
Journal:  N Engl J Med       Date:  2006-11-02       Impact factor: 91.245

10.  Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

Authors:  L Bastholt; M Dalmark; S B Gjedde; P Pfeiffer; D Pedersen; E Sandberg; M Kjaer; H T Mouridsen; C Rose; O S Nielsen; P Jakobsen; S M Bentzen
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

View more
  3 in total

1.  A label-free electrochemical biosensor based on 3D cubic Eu3+/Cu2O nanostructures with clover-like faces for the determination of anticancer drug cytarabine.

Authors:  Mohammad Mehdi Foroughi; Shohreh Jahani; Zahra Aramesh-Broujeni; Meisam Rostaminasab Dolatabad
Journal:  RSC Adv       Date:  2021-05-13       Impact factor: 4.036

2.  Simultaneous determination of methadone and morphine at a modified electrode with 3D β-MnO2 nanoflowers: application for pharmaceutical sample analysis.

Authors:  Sedigheh Akbari; Shohreh Jahani; Mohammad Mehdi Foroughi; Hadi Hassani Nadiki
Journal:  RSC Adv       Date:  2020-10-19       Impact factor: 4.036

3.  A DNA Biosensor Based on a Raspberry-like Hierarchical Nano-structure for the Determination of the Anticancer Drug Nilotinib.

Authors:  Mohammad Mehdi Moarefdoust; Shohreh Jahani; Mehran Moradalizadeh; Mohammad Mehdi Motaghi; Mohammad Mehdi Foroughi
Journal:  ChemistryOpen       Date:  2022-03       Impact factor: 2.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.